A Service Level Agreement (SLA) is a formal contract between a service provider and a client that defines the expected level of service. It outlines specific metrics, responsibilities, and expectations for the delivery of services, such as performance standards, response times, and availability.
SLAs are commonly used in clinical research to establish clear guidelines for outsourced services, like data management or laboratory analysis. They help ensure quality, timeliness, and accountability in the execution of clinical trials, while also providing a framework for measuring and evaluating service performance.
Service Level Agreements are crucial in clinical research as they establish clear expectations and standards for outsourced services, ensuring consistent quality and timely delivery. By defining specific metrics and performance criteria, SLAs help maintain the integrity and reliability of clinical trial data, which is essential for regulatory compliance and the overall success of research projects.
Furthermore, SLAs provide a mechanism for accountability and performance evaluation in clinical research partnerships. They enable sponsors and Contract Research Organizations (CROs) to objectively assess service quality, address issues promptly, and make data-driven decisions about vendor relationships, ultimately contributing to more efficient and cost-effective clinical trial management.
We’re pleased to announce a strategic partnership between Axcellant and Prometheus MedTech.AI — a medtech startup developing AI-powered solutions for…
The Axcellant team has returned from the European Association of Nuclear Medicine (EANM) Annual Congress in Barcelona — and it’s…
The robust development of nuclear medicine depends on the availability of radioactive isotopes, some of which are used for diagnostic…
Copyright @ 2025 Axcellant